Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bienaimé F[au]:

Antiphospholipid syndrome and kidney disease. Bienaimé F et al. Kidney Int. (2017)

Inhibition of the mTORC pathway in the antiphospholipid syndrome. Canaud G et al. N Engl J Med. (2014)

Endoplasmic reticulum stress drives proteinuria-induced kidney lesions via Lipocalin 2. El Karoui K et al. Nat Commun. (2016)

Search results

Items: 25

1.

Osmoregulation Performance and Kidney Transplant Outcome.

Mazloum M, Jouffroy J, Brazier F, Legendre C, Neuraz A, Garcelon N, Prié D, Anglicheau D, Bienaimé F.

J Am Soc Nephrol. 2019 Jul;30(7):1282-1293. doi: 10.1681/ASN.2018121269. Epub 2019 Jun 19.

PMID:
31217325
2.

Cilia-localized LKB1 regulates chemokine signaling, macrophage recruitment, and tissue homeostasis in the kidney.

Viau A, Bienaimé F, Lukas K, Todkar AP, Knoll M, Yakulov TA, Hofherr A, Kretz O, Helmstädter M, Reichardt W, Braeg S, Aschman T, Merkle A, Pfeifer D, Dumit VI, Gubler MC, Nitschke R, Huber TB, Terzi F, Dengjel J, Grahammer F, Köttgen M, Busch H, Boerries M, Walz G, Triantafyllopoulou A, Kuehn EW.

EMBO J. 2018 Aug 1;37(15). pii: e98615. doi: 10.15252/embj.201798615. Epub 2018 Jun 19.

3.

Hepatic Production of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease.

Bienaimé F, Ambolet A, Aussilhou B, Brazier F, Fouchard M, Viau A, Barre P, Tissier AM, Correas JM, Paradis V, Terzi F, Friedlander G, Knebelmann B, Joly D, Prié D.

J Clin Endocrinol Metab. 2018 Jun 1;103(6):2319-2328. doi: 10.1210/jc.2018-00123.

PMID:
29618028
4.

The Association Between Fibroblast Growth Factor 23 and Renal Transplantation Outcome Is Modified by Follow-up Duration and Glomerular Filtration Rate Assessment Method.

Bienaimé F, Dechartres A, Anglicheau D, Sabbah L, Montgermont P, Friedlander G, Ravaud P, Legendre C, Prié D.

Kidney Int Rep. 2017 May 18;2(5):881-892. doi: 10.1016/j.ekir.2017.05.007. eCollection 2017 Sep.

5.

Efficient genome editing of differentiated renal epithelial cells.

Hofherr A, Busch T, Huber N, Nold A, Bohn A, Viau A, Bienaimé F, Kuehn EW, Arnold SJ, Köttgen M.

Pflugers Arch. 2017 Feb;469(2):303-311. doi: 10.1007/s00424-016-1924-4. Epub 2016 Dec 16.

6.

Antiphospholipid syndrome and kidney disease.

Bienaimé F, Legendre C, Terzi F, Canaud G.

Kidney Int. 2017 Jan;91(1):34-44. doi: 10.1016/j.kint.2016.06.026. Epub 2016 Aug 21. Review.

PMID:
27555120
7.

Stat3 Controls Tubulointerstitial Communication during CKD.

Bienaimé F, Muorah M, Yammine L, Burtin M, Nguyen C, Baron W, Garbay S, Viau A, Broueilh M, Blanc T, Peters D, Poli V, Anglicheau D, Friedlander G, Pontoglio M, Gallazzini M, Terzi F.

J Am Soc Nephrol. 2016 Dec;27(12):3690-3705. Epub 2016 May 6.

8.

Molecular pathways of chronic kidney disease progression.

Bienaimé F, Canaud G, El Karoui K, Gallazzini M, Terzi F.

Nephrol Ther. 2016 Apr;12 Suppl 1:S35-8. doi: 10.1016/j.nephro.2016.02.009. Epub 2016 Mar 10. Review.

PMID:
26972095
9.

Endoplasmic reticulum stress drives proteinuria-induced kidney lesions via Lipocalin 2.

El Karoui K, Viau A, Dellis O, Bagattin A, Nguyen C, Baron W, Burtin M, Broueilh M, Heidet L, Mollet G, Druilhe A, Antignac C, Knebelmann B, Friedlander G, Bienaimé F, Gallazzini M, Terzi F.

Nat Commun. 2016 Jan 20;7:10330. doi: 10.1038/ncomms10330.

10.

Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.

Figueres ML, Linglart A, Bienaime F, Allain-Launay E, Roussey-Kessler G, Ryckewaert A, Kottler ML, Hourmant M.

Am J Kidney Dis. 2015 Jan;65(1):122-6. doi: 10.1053/j.ajkd.2014.06.037. Epub 2014 Nov 4.

PMID:
25446019
11.

Inhibition of the mTORC pathway in the antiphospholipid syndrome.

Canaud G, Bienaimé F, Tabarin F, Bataillon G, Seilhean D, Noël LH, Dragon-Durey MA, Snanoudj R, Friedlander G, Halbwachs-Mecarelli L, Legendre C, Terzi F.

N Engl J Med. 2014 Jul 24;371(4):303-12. doi: 10.1056/NEJMoa1312890.

12.

The kidney as a reservoir for HIV-1 after renal transplantation.

Canaud G, Dejucq-Rainsford N, Avettand-Fenoël V, Viard JP, Anglicheau D, Bienaimé F, Muorah M, Galmiche L, Gribouval O, Noël LH, Satie AP, Martinez F, Sberro-Soussan R, Scemla A, Gubler MC, Friedlander G, Antignac C, Timsit MO, Onetti Muda A, Terzi F, Rouzioux C, Legendre C.

J Am Soc Nephrol. 2014 Feb;25(2):407-19. doi: 10.1681/ASN.2013050564. Epub 2013 Dec 5.

13.

AKT2 is essential to maintain podocyte viability and function during chronic kidney disease.

Canaud G, Bienaimé F, Viau A, Treins C, Baron W, Nguyen C, Burtin M, Berissi S, Giannakakis K, Muda AO, Zschiedrich S, Huber TB, Friedlander G, Legendre C, Pontoglio M, Pende M, Terzi F.

Nat Med. 2013 Oct;19(10):1288-96. doi: 10.1038/nm.3313. Epub 2013 Sep 22.

PMID:
24056770
14.

Vitamin D status and outcomes after renal transplantation.

Bienaimé F, Girard D, Anglicheau D, Canaud G, Souberbielle JC, Kreis H, Noël LH, Friedlander G, Elie C, Legendre C, Prié D.

J Am Soc Nephrol. 2013 Apr;24(5):831-41. doi: 10.1681/ASN.2012060614. Epub 2013 Mar 28.

15.

Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.

Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaimé F, Dragon-Durey MA, Ngo S, Moulin B, Servais A, Provot F, Rostaing L, Burtey S, Niaudet P, Deschênes G, Lebranchu Y, Zuber J, Loirat C.

Clin J Am Soc Nephrol. 2013 Apr;8(4):554-62. doi: 10.2215/CJN.04760512. Epub 2013 Jan 10.

16.

A transcriptional network underlies susceptibility to kidney disease progression.

Laouari D, Burtin M, Phelep A, Bienaime F, Noel LH, Lee DC, Legendre C, Friedlander G, Pontoglio M, Terzi F.

EMBO Mol Med. 2012 Aug;4(8):825-39. doi: 10.1002/emmm.201101127. Epub 2012 Jun 18.

17.

Vitamin D and primary hyperparathyroidism (PHPT).

Souberbielle JC, Bienaimé F, Cavalier E, Cormier C.

Ann Endocrinol (Paris). 2012 Jun;73(3):165-9. doi: 10.1016/j.ando.2012.04.008. Epub 2012 Jun 5. Review.

PMID:
22677209
18.

Vitamin D metabolism and activity in the parathyroid gland.

Bienaimé F, Prié D, Friedlander G, Souberbielle JC.

Mol Cell Endocrinol. 2011 Dec 5;347(1-2):30-41. doi: 10.1016/j.mce.2011.05.031. Epub 2011 Jun 1. Review.

PMID:
21664247
19.

Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies.

Canaud G, Bienaimé F, Noël LH, Royal V, Alyanakian MA, Dautzenberg MD, Rabant M, Posson J, Thervet E, Anglicheau D, Kreis H, Martinez F, Legendre C, Zuber J.

Am J Transplant. 2010 Sep;10(9):2051-60. doi: 10.1111/j.1600-6143.2010.03233.x.

20.

Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level?

Canaud G, Knebelmann B, Harris PC, Vrtovsnik F, Correas JM, Pallet N, Heyer CM, Letavernier E, Bienaimé F, Thervet E, Martinez F, Terzi F, Legendre C.

Am J Transplant. 2010 Jul;10(7):1701-6. doi: 10.1111/j.1600-6143.2010.03152.x.

21.

Lupus nephritis associated with complete C1s deficiency efficiently treated with rituximab: a case report.

Bienaimé F, Quartier P, Dragon-Durey MA, Frémeaux-Bacchi V, Bader-Meunier B, Patey N, Salomon R, Noël LH.

Arthritis Care Res (Hoboken). 2010 Sep;62(9):1346-50. doi: 10.1002/acr.20163. No abstract available.

22.

Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome.

Bienaime F, Dragon-Durey MA, Regnier CH, Nilsson SC, Kwan WH, Blouin J, Jablonski M, Renault N, Rameix-Welti MA, Loirat C, Sautés-Fridman C, Villoutreix BO, Blom AM, Fremeaux-Bacchi V.

Kidney Int. 2010 Feb;77(4):339-49. doi: 10.1038/ki.2009.472. Epub 2009 Dec 16.

23.

D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease.

Bienaimé F, Clerbaux G, Plaisier E, Mougenot B, Ronco P, Rougier JP.

Am J Kidney Dis. 2007 Nov;50(5):821-5.

PMID:
17954295
24.

Recurrence of hemolytic uremic syndrome after renal transplantation.

Seitz B, Albano L, Vocila F, Mzoughi S, Aoudia R, Guitard J, Ribes D, Vachet-Copponat H, Mourad G, Bienaimé F, Dahan P, Frémeaux-Bacchi V, Cassuto E.

Transplant Proc. 2007 Oct;39(8):2583-5.

PMID:
17954182
25.

Hereditary complement C7 deficiency in nine families: subtotal C7 deficiency revisited.

Rameix-Welti MA, Régnier CH, Bienaimé F, Blouin J, Schifferli J, Fridman WH, Sautès-Fridman C, Frémeaux-Bacchi V.

Eur J Immunol. 2007 May;37(5):1377-85.

Supplemental Content

Loading ...
Support Center